Pharma Firms

The company has registered 10% growth in revenues at Rs 4,431.8 cr for the quarter under review from Rs 4,016.6 cr in the year-ago period

Updated On: 21 May 2020 | 2:27 AM IST

Export growth started declining in February and turned negative in March, at -23.24 per cent

Updated On: 08 May 2020 | 6:24 PM IST

Over 133 million shares, or 5.7% of the paid-up capital, are being offered for Rs 1,850-1,950 to investors through a special block window

Updated On: 07 May 2020 | 3:31 AM IST

8 Malaysians caught trying to leave India

Updated On: 05 Apr 2020 | 8:44 PM IST

The matter will come up again in court on Monday

Updated On: 22 Feb 2020 | 10:49 PM IST

The expansion of WBA and TCS strategic partnership is based on WBA's review of its IT operating model and vendor landscape

Updated On: 03 Feb 2020 | 10:25 PM IST

There is a plan to identify a list of essential medicines, including antibiotics, painkillers, etc, which the company may supply to the Ayushman Bharat-empanelled hospitals.

Updated On: 18 Dec 2019 | 2:16 PM IST

Ogivri will be launched at a competitive discount for customers to help ensure access and increase treatment options for patients

Updated On: 02 Dec 2019 | 7:56 PM IST

The Street is cautious given multiple challenges in core markets of US and India

Updated On: 18 Aug 2019 | 8:22 PM IST

The companies' combined net profit declined by 10.1 per cent yoy during June '19 quarter against 26.2 per cent yoy growth a year ago

Updated On: 15 Aug 2019 | 11:50 PM IST

In India, the company said it will focus on therapeutic segments like diabetes, dermatology, cardiology and women's health

Updated On: 29 Jul 2019 | 1:30 AM IST

According to Edelweiss Securities, pharma sales to grow by 17 per cent YoY as US sales are expected to grow by 21 per cent YoY

Updated On: 22 Jul 2019 | 1:44 PM IST

The BSE Healthcare Index has fallen 10 per cent in the last one year

Updated On: 04 Jul 2019 | 11:44 PM IST

Top 10 brands (of a company) account for more than 20 per cent of their domestic revenue in the case of most, analysts said

Updated On: 02 Jul 2019 | 10:06 PM IST

Impact of an escalation of the observations will hit their profit estimates over the next couple of years

Updated On: 04 Jun 2019 | 9:46 PM IST

44 states have alleged the drugmakers of price fixing

Updated On: 14 May 2019 | 2:03 AM IST

This decline was primarily for two reasons. One, commoditisation of generics led to price erosion. Two, investments increased in both R&D and in expansion

Updated On: 03 Feb 2019 | 10:06 PM IST

Around 17 per cent of the Rs 1.2-trillion domestic pharma market is currently under price control

Updated On: 04 Jan 2019 | 2:39 AM IST

Easing of pricing pressures, launch of limited competition drugs in the US, weak rupee are key triggers

Updated On: 12 Nov 2018 | 12:16 AM IST

The government is also mooting a cooperative manufacturing model for small units

Updated On: 20 Sep 2018 | 9:31 AM IST